Albany, NY, Oct. 29, 2014 (GLOBE NEWSWIRE) -- Transparency Market Research, in its report titled 'Peptide Therapeutics Market (by Synthesis - SPPS, LPPS, HPPS, by Application - Cancer, Metabolic, CVS, CNS & others, by Types - Innovative & Generic and by Delivery) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018', states that the global peptide therapeutics market was worth US$14.1 billion in 2011 and is expected to reach US$25.4 billion by 2018 at an 8.7% CAGR.
The two main types of peptide therapeutics are innovative and generic. Peptide therapeutics finds applications in disciplines such as cardiovascular, dermatology, metabolic, cancer, neurology, gastro intestinal, pain, renal, anti-infection, and respiratory. On the basis of route of administration, peptide therapeutics can be segmented into oral, parenteral, mucosal, and pulmonary. On the basis of technology, peptide therapeutics is divided into solid phase peptide synthesis, liquid phase peptide synthesis, and hybrid. On the basis of API peptide, the market for peptide therapeutics is categorized into in-house and contract manufacturing organization.
Browse Full Report : http://www.transparencymarketresearch.com/peptide-therapeutics-market.html
Among the major applications, cancer peptide was the largest segment, accounting for 21% of the peptide therapeutics market. With rising incidences of Parkinson's and Alzheimer's disease, the neuropeptides segment will grow at 9.4% CAGR in the forecast period. Among the main routes of peptide therapeutics administration, the parenteral segment accounted for 86% of the market share in 2011. Combing the best of both solid and liquid phase peptide synthesis, the hybrid technology segment of the peptide therapeutics market is expected to register the highest CAGR of 12.1% during the forecast period. North America dominated the global peptide therapeutics market, accounting for 40% of the overall industry.
Some of the major factors that fuel the peptide therapeutics market are increasing number of cancer patients, rising cases of metabolic disorders, technological advancement, and mounting R&D activities as well as pipeline drugs in the field of peptide therapeutics. With the possibility of patent cliff in the near future, the generic peptide segment is expected to grow significantly, thereby leading to the overall propulsion of the peptide therapeutics market. In addition, industry analysts foresee great potential in the collaboration of small peptide therapeutics firms with major pharmaceutical companies. Rising cancer vaccines are also expected to stimulate the peptide therapeutics market.
Get The Sample Report PDF : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=418
However, absence of effective regularity standards for peptide therapeutics, attempting to match customer requirements with the equipment, and rising complexities of peptides are expected to inhibit the global peptide therapeutics market.
Related Published Report By Transparency Market Research :
- Stem Cells Market : http://www.transparencymarketresearch.com/stem-cells-market.html
- Regenerative Medicine Market : http://www.transparencymarketresearch.com/regenerative-medicines-market.html
As the global peptide therapeutics market gains significance, there has been a surge of new entrants in the industry. Some of the major peptide therapeutics companies include Roche, Ipsen, Novo-Nordisk, Eli LillyAmylin. The CMOs in the peptide therapeutics market include Peptisyntha, Bachem, Lonza, and Polypeptide Group.
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
CONTACT: Sheela AK 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA/Canada Toll Free: 866-552-3453 Email: firstname.lastname@example.org Web: http://www.transparencymarketresearch.com/ Blog: http://www.tmrblog.com/ Blog: http://transparencymarketresearch.areavoices.com/
Source:Transparency Market Research